TrialKidney international2015

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Stephen R Ash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.